Attached files
file | filename |
---|---|
10-K - FORM 10-K - ALNYLAM PHARMACEUTICALS, INC. | d835246d10k.htm |
EX-21.1 - EX-21.1 - ALNYLAM PHARMACEUTICALS, INC. | d835246dex211.htm |
EXCEL - IDEA: XBRL DOCUMENT - ALNYLAM PHARMACEUTICALS, INC. | Financial_Report.xls |
EX-23.1 - EX-23.1 - ALNYLAM PHARMACEUTICALS, INC. | d835246dex231.htm |
EX-32.1 - EX-32.1 - ALNYLAM PHARMACEUTICALS, INC. | d835246dex321.htm |
EX-32.2 - EX-32.2 - ALNYLAM PHARMACEUTICALS, INC. | d835246dex322.htm |
EX-31.2 - EX-31.2 - ALNYLAM PHARMACEUTICALS, INC. | d835246dex312.htm |
EX-31.1 - EX-31.1 - ALNYLAM PHARMACEUTICALS, INC. | d835246dex311.htm |
Exhibit 12
STATEMENT REGARDING COMPUTATION OF CONSOLIDATED RATIOS OF EARNINGS/DEFICIENCIES TO FIXED CHARGES
(dollars in thousands)
Fiscal Year Ended December 31, | ||||||||||||||||||||||||
2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |||||||||||||||||||
Earnings (loss): |
||||||||||||||||||||||||
Pre-tax loss from continuing operations before adjustment for loss from equity investee |
$ | (400,604 | ) | $ | (91,920 | ) | $ | (112,064 | ) | $ | (54,144 | ) | $ | (35,362 | ) | $ | (42,098 | ) | ||||||
add: Fixed charges (see below) |
1,719 | 678 | 1,188 | 1,207 | 1,207 | 712 | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Pre-tax loss from continuing operations before adjustment for income/loss from equity investees plus fixed charges |
$ | (398,885 | ) | $ | (91,242 | ) | $ | (110,876 | ) | $ | (52,937 | ) | $ | (34,155 | ) | $ | (41,386 | ) | ||||||
Fixed charges: |
||||||||||||||||||||||||
Interest expense on portion of rent expense representative of interest |
$ | 1,719 | $ | 678 | $ | 1,188 | $ | 1,207 | $ | 1,207 | $ | 712 | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Total fixed charges |
$ | 1,719 | $ | 678 | $ | 1,188 | $ | 1,207 | $ | 1,207 | $ | 712 | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Ratio of earnings to fixed charges |
| | | | | | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Deficiency of earnings available to cover fixed charges |
$ | (400,604 | ) | $ | (91,920 | ) | $ | (112,064 | ) | $ | (54,144 | ) | $ | (35,362 | ) | $ | (42,098 | ) | ||||||
|
|
|
|
|
|
|
|
|
|
|
|